Hostname: page-component-745bb68f8f-kw2vx Total loading time: 0 Render date: 2025-01-22T16:59:17.990Z Has data issue: false hasContentIssue false
  • English
  • Français

Nerve Microvessel Changes in Diabetes are Prevented by Aldose Reductase Inhibition

Published online by Cambridge University Press:  18 September 2015

Timothy J. Benstead  and
Virgilio E. Sangalang
Timothy J. Benstead*
Affiliation:
Department of Medicine, Dalhousie University, Halifax
Virgilio E. Sangalang
Affiliation:
Department of Pathology, Dalhousie University, Halifax
*
Division of Neurology, Department of Medicine. Dalhousie University, Victoria General Hospital, Halifax, Nova Scotia. Canada B3H 2Y9
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background

Despite the potential importance of endoneurial microvessel abnormalities in diabetic neuropathy, the pathogenesis of these abnormalities is incompletely understood. We wished to evaluate the effect of experimental diabetes on endoneurial microvessels and determine if an aldose reductase inhibitor alters any of the changes induced by diabetes.

Methods

We compared streptozocin diabetic rats with and without aldose reductase inhibitor treatment to non-diabetic rats after 10 months of diabetes. Transverse microvessels from the mid-sciatic level were studied by electron microscopic morphometric evaluation.

Results

Microvessel endothelial, pericyte, basement membrane and total mural area were greater in untreated diabetic animals than non-diabetic animals. Aldose reductase inhibitor treated diabetic animals had greater endothelial area and possibly pericyte area but not basement membrane or total mural area.

Conclusions

This study demonstrates that endoneurial microvessel abnormalities can be detected in experimental diabetic neuropathy. Microvessel basement membrane thickening will be prevented by an aldose reductase inhibitor. One mechanism by which abnormal polyol pathway activity may contribute to diabetic neuropathy could be through damage to microvessels.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 22 , Issue 3 , August 1995 , pp. 192 - 197
Copyright
Copyright © Canadian Neurological Sciences Federation 1995

References

1.Mayer, JH, Tomlinson, DR.Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myoinositol or an aldose reductase inhibitor in streptozotocin-diabetic rats. Diabetologia 1983; 25: 433–438.CrossRefGoogle ScholarPubMed
2.Yue, DK, Hanwell, MA, Satchell, PM, Turtle, JR.The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats. Diabetes 1982; 31: 789–794.CrossRefGoogle ScholarPubMed
3.Judzewitsch, RG, Jaspan, JB, Polonsky, KS, et. al. Aldose reductase inhibition improves nerve conduction velocity in diabetic patients. N Engl J Med 1983; 308: 119–125.CrossRefGoogle ScholarPubMed
4.Sima, AAF, Bril, V, Nathaniel, V, et. al. Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil. N Engl J Med 1988; 319: 548–555.CrossRefGoogle ScholarPubMed
5.Gabbay, KH, O’Sullivan, JB.The sorbitol pathway: enzyme localization and content in normal and diabetic nerve and cord. Diabetes 1968; 17: 239–243.CrossRefGoogle ScholarPubMed
6.Hale, PJ, Nattrass, M, Silverman, SH, et. al. Peripheral nerve concentrations of glucose, fructose, sorbitol and myoinositol in diabetic and non-diabetic patients. Diabetologia 1987; 30: 464–467.CrossRefGoogle ScholarPubMed
7.Greene, DA, Lewis, RA, Lattimer, SA, Brown, MJ.Selective effects of myo-inositol administration on sciatic and tibial motor nerve conduction parameters in the streptozocin diabetic rat. Diabetes 1982; 31: 573–578.CrossRefGoogle ScholarPubMed
8.Greene, DA, Lattimer, SA.Impaired rat sciatic nerve sodium-potassium adenosinetriphosphate in acute streptozotocin diabetes and its correction by dietary myo-inositol supplementation. J Clin Invest 1983; 72: 1058–1063.CrossRefGoogle Scholar
9.Greene, DA, Chakrabarti, S, Lattimer, SA, Sima, AA.Role of sorbitol accumulation and myo-inositol depletion in paranodal swelling of large myelinated nerve fibers in the insulin-deficient spontaneously diabetic bio-breeding rat: reversal by insulin replacement, an aldose reductase inhibitor and myo-inositol. J Clin Invest 1987; 79: 1479–1485.CrossRefGoogle ScholarPubMed
10.Sima, AA, Lattimer, SA, Yagihashi, S, Greene, DA.Axo-glial dysjunction: a novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat. J Clin Invest 1986; 77: 474–484.CrossRefGoogle ScholarPubMed
11.Sima, AAF, Brismar, T.Reversible diabetic nerve dysfunction: structural correlates to electrophysiological abnormalities. Ann Neurol 1985; 18: 21–29.CrossRefGoogle ScholarPubMed
12.Dyck, PJ, Lais, A, Karnes, JL, O’Brien, P, Rizza, R.Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy. Ann Neurol 1986; 19: 425–439.CrossRefGoogle ScholarPubMed
13.Dyck, PJ, Karnes, JL, O’Brien, P, et al. The spatial pattern of fiber loss in diabetic polyneuropathy suggests ischemia. Ann Neurol 1986; 19: 440–449.CrossRefGoogle ScholarPubMed
14.Johnson, PC, Doll, SC, Cromey, DW.Pathogenesis of diabetic neuropathy. Ann Neurol 1986; 19: 450–457.CrossRefGoogle ScholarPubMed
15.Raff, MC, Sangalang, V, Asbury, AK.Ischemic mononeuropathy multiplex associated with diabetes mellitus. Arch Neurol 1968; 18: 487–499.CrossRefGoogle ScholarPubMed
16.Malik, RA, Newrick, PG, Sharma, AK, et al. Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia 1989; 32: 92–102.CrossRefGoogle ScholarPubMed
17.Yasuda, H, Dyck, PJ.Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy. Neurology 1987; 37: 20–28.CrossRefGoogle ScholarPubMed
18.Dyck, PJ, Hansen, S, Karnes, J, et al. Capillary number and percentage closed in human diabetic sural nerve. Proc Natl Acad Sci USA 1985; 82: 2513–2517.CrossRefGoogle ScholarPubMed
19.Chakrabarti, S, Sima, AAF, Nakajima, T, Yagihashi, S, Greene, DA.Aldose reductase in the BB rat: isolation, immunological identification and localization in the retina and peripheral nerve. Diabetologia 1987; 30: 244–251.CrossRefGoogle ScholarPubMed
20.Robison, WG, Kador, PF, Kinoshita, JH.Retinal capillaries: basement membrane thickening by galactosemia prevented with aldose reductase inhibitor. Science 1983; 221: 1177–1179.CrossRefGoogle ScholarPubMed
21.Frank, RN, Keirn, RJ, Kennedy, A, Frank, KW.Galactose-induced retinal capillary basement membrane thickening: prevention by sorbinil. Invest Ophthalmol Vis Sci 1983; 24: 1519–1524.Google ScholarPubMed
22.Powell, HC, Myers, RR.Axonopathy and microangiopathy in chronic alloxan diabetes. Acta Neuropathol (Berl) 1984; 65: 128–137.CrossRefGoogle ScholarPubMed
23.Stribling, D, Mirrlees, DJ, Harrison, HE, Earl, DCN.Properties of ICI 128, 436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the rat. Metabolism 1985; 34: 336–344.CrossRefGoogle ScholarPubMed
24.Sladky, JT, Greenberg, JH, Brown, MJ.Regional perfusion in normal and ischemic rat sciatic nerves. Ann Neurol 1985; 17: 191–195.CrossRefGoogle ScholarPubMed
25.Nukada, H, Dyck, PJ.Microsphere embolization of nerve capillaries and fiber degeneration. Am J Pathol 1984; 115: 275–287.Google ScholarPubMed
26.Benstead, TJ, Sangalang, VE, Dyck, PJ.Acute endothelial swelling is induced in endoneurial microvessels by ischemia. J Neurol Sci 1990; 99: 37–49.CrossRefGoogle ScholarPubMed
27.Sharma, AK, Bajada, S, Thomas, PK.Influence of streptozotocin-induced diabetes on myelinated nerve fibre maturation and on body growth in the rat. Acta Neuropathol (Berl) 1981; 53: 257–265.CrossRefGoogle ScholarPubMed
28.Britland, ST, Young, RJ, Sharma, AK, Clarke, BF.Relationship of endoneurial capillary abnormalities to type and severity of diabetic neuropathy. Diabetes 1990; 39: 909–913.CrossRefGoogle Scholar
29.Williams, E, Timperley, WR, Ward, JD, Duckworth, T.Electron microscopical studies of vessels in diabetic peripheral neuropathy. J Clin Pathol 1980; 33: 462–470.CrossRefGoogle ScholarPubMed
30.Low, PA, Nukada, H, Schmelzer, JD, Tuck, RR, Dyck, PJ.Endoneurial oxygen tension and radial topography in nerve edema. Brain Res 1985,341: 147–154.CrossRefGoogle ScholarPubMed
31.Tuck, RR, Schmelzer, JD, Low, PA.Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain 1984; 107: 935–950.CrossRefGoogle ScholarPubMed
32.Boulton, AJM, Scarpello, JHB, Ward, JD.Venous oxygenation in the diabetic neuropathic foot: evidence of arteriovenous shunting? Diabetologia 1982; 22: 6–8.CrossRefGoogle ScholarPubMed
33.Newrick, PG, Wilson, AJ, Jakubowski, J, Boulton, AJM, Ward, JD.Sural nerve oxygen tension in diabetes. Br Med J 1986; 293: 1053–1054.CrossRefGoogle ScholarPubMed
34.Low, PA, Schmelzer, JD, Ward, KK, Yao, JK.Experimental chronic hypoxic neuropathy: relevance to diabetic neuropathy. Am J Physiol 1986; 251: E94–E99.Google Scholar
35.Benstead, TJ, Dyck, PJ, Low, P.Chronic hypoxia induces selective maldevelopment of peripheral myelin in rat. J Neuropathol Exp Neurol 1988; 47: 599–608.CrossRefGoogle ScholarPubMed
36.Low, PA, Tuck, RR, Dyck, PJ, Schmelzer, JD, Yao, JK.Prevention of some electrophysiologic and biochemical abnormalities with oxygen supplementation in experimental diabetic neuropathy. Proc Natl Acad Sci USA 1984; 81: 6894–6898.CrossRefGoogle ScholarPubMed
37.Benstead, TJ, Dyck, PJ, Sangalang, V.Inner perineurial cell vulnerability in ischemia. Brain Res 1989; 489: 177–181.CrossRefGoogle ScholarPubMed
38.Ward, KK, Low, PA, Schmelzer, JD, Zochodne, DW.Prostacyclin and noradrenaline in peripheral nerve of chronic experimental diabetes in rats. Brain 1989; 112: 197–208.CrossRefGoogle ScholarPubMed
39.Weksler, BB, Marcus, AJ, Jaffe, EA.Synthesis of prostaglandin 12 (prostacyclin) by cultured human and bovine endothelial cells. Proc Natl Acad Sci USA 1977; 74: 3922–3926.CrossRefGoogle Scholar
40.Branemark, P-L, Lindstrom, J.Shape of circulating blood corpuscles. Biorheology 1963; 1: 139–142.Google Scholar
41.Guest, MM, Bond, TP, Cooper, RG, Derrick, JR.Red blood cells: change in shape in capillaries. Science 1963; 142: 1319–1321.CrossRefGoogle ScholarPubMed
42.Williamson, JR, Chang, K, Frangos, M, et al. Hyperglycemic pseudo-hypoxia and diabetic complications. Diabetes 1993; 42: 801–813.CrossRefGoogle Scholar
43.Kador, PF, Kinoshita, JH.Role of aldose reductase in the development of diabetes-associated complications. Am J Med 1985; 79 (Suppl 5A): 8–12.CrossRefGoogle ScholarPubMed
44.Hu, T-S, Datiles, M, Kinoshita, JH.Reversal of galactose cataract with sorbinil in rats. Invest Ophthalmol Vis Sci 1983; 24: 640–644.Google ScholarPubMed
45.Dyck, PJ, Zimmerman, BR, Vilen, TH, et. al. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy. N Engl J Med 1988; 319: 542–548.CrossRefGoogle ScholarPubMed
46.Brismar, T, Sima, AAF.Changes in nodal function in nerve fibers of the spontaneously diabetic BB-Wistar rat. Potential clamp analysis. Acta Physiol Scand 1981; 113: 499–506.CrossRefGoogle ScholarPubMed
47.Nathan, C.Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6: 3051–3064.CrossRefGoogle ScholarPubMed
48.Brownlee, M, Vlassara, H, Kooney, A, Ulrich, P, Cerami, A.Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 1986; 232: 1629–1632.CrossRefGoogle ScholarPubMed
49.Cameron, NE, Cotter, MA, Dines, K, Love, A.Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia 1992; 35: 946–950.CrossRefGoogle ScholarPubMed
50.Corbett, JA, Tilton, RG, Chang, K, et al. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 1992; 41: 552–556.CrossRefGoogle ScholarPubMed
51.Bradley, J, Thomas, PK, King, RH, et al. Morphometry of endoneurial capilaries in diabetic sensory and autonomic neuropathy. Diabetologia 1990; 33: 611–618.CrossRefGoogle Scholar
52.Jakobsen, J.Axonal dwindling in early experimental diabetes. II. A study of isolated nerve fibres. Diabetologia 1976; 12: 547–553.CrossRefGoogle Scholar
53.Mizisin, AP, Powell, HC.Schwann cell injury is attenuated by aldose reductase inhibition in galactose intoxication. J Neuropathol Exp Neurol 1993; 52: 78–86.CrossRefGoogle ScholarPubMed